These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16048116)

  • 21. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 22. Microbiological tests on oral pediatric medicines--requirements for an improved pharmacopoeia monograph.
    Long PF; Han J; Tuleu C; Wong IC
    Ann Pharmacother; 2006 Jan; 40(1):158-9. PubMed ID: 16368921
    [No Abstract]   [Full Text] [Related]  

  • 23. US Pharmacopeia Council of Experts 2005-2010: work plans, new revision approaches, and other enhancements.
    Williams RL
    AAPS J; 2006; 8(4):E661-4. PubMed ID: 17285738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extemporaneously compounded sterile medications: relevance of new United States pharmacopeial standards to pain clinicians.
    Rusho WJ
    J Pain Palliat Care Pharmacother; 2004; 18(4):69-76. PubMed ID: 15760810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential impact of USP 797 and what the JCAAI is doing about it.
    Nathan R
    Allergy Asthma Proc; 2007; 28(2):236-7. PubMed ID: 17479611
    [No Abstract]   [Full Text] [Related]  

  • 26. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
    Kastango ES; Bradshaw BD
    Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
    [No Abstract]   [Full Text] [Related]  

  • 27. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 28. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 29. Establishment of galenic laboratories in developing countries to produce high quality medicines: results of Aid Progress Pharmacist Agreement (A.P.P.A.®) Project.
    Baratta F; Germano A; Di Lascio G; Petieau R; Brusa P
    Croat Med J; 2014 Dec; 55(6):662-8. PubMed ID: 25559838
    [No Abstract]   [Full Text] [Related]  

  • 30. Revisions continue on USP sterile-compounding chapter.
    Thompson CA
    Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
    [No Abstract]   [Full Text] [Related]  

  • 31. Basics of sterile compounding: bubble point testing.
    Thoma L
    Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-way distribution system for water for injection: process management, microbiological quality control, and meeting regulatory requirements.
    Jahnke M
    PDA J Pharm Sci Technol; 2001; 55(1):3-9. PubMed ID: 11212418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The microbiological faultlessness of drugs. III. Development and problems of testing methods].
    Sagáth J; Chalabala M; Bábik I
    Cesk Farm; 1978 Oct; 27(8):353-8. PubMed ID: 743754
    [No Abstract]   [Full Text] [Related]  

  • 34. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
    Vu N; Nguyen K; Kupiec TC
    Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Minimum requirements for the microbiological control of blood components for transfusion. Update of the vote 16].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Mar; 56(3):474-5. PubMed ID: 23455562
    [No Abstract]   [Full Text] [Related]  

  • 37. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality Control-Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding.
    Allen LV
    Int J Pharm Compd; 2018; 22(3):206-217. PubMed ID: 29878889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.